1 completed, 1 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Vancomycin Continuous Infusion: new trials by email Literature Review of Vancomycin Continuous Infusion trials Research Report on Vancomycin Continuous Infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous vs. Intermittent Infusion Vancomycin Vancomycin Continuous Infusion, Vancomycin Intermittent Infusion - Vancomycin | Phase 4 | Completed | Aaron Cook | 37 | 2023-05-22 | 2025-12-15 |
| Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients Vancomycin Continuous infusion, Vancomycin Intermittent infusion - Gram-Positive Bacterial Infections, Nephrotoxicity | Phase 4 | Unknown | University of Sao Paulo | 222 | 2018-04-28 | 2018-04-05 |
| Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients Vancomycin continuous infusion, Vancomycin intermittent dosing interval - MRSA - Methicillin Resistant Staphylococcus Aureus Infection | Phase 4 | Terminated | Massachusetts General Hospital | 44 | 2013-09-01 | 2017-06-07 |
Acute Kidney Injury (1) · Gram-Positive Bacterial Infections (1) · Sepsis (1)
Aaron Cook (1) · Massachusetts General Hospital (1) · University of Sao Paulo (1)
United States (2) · Brazil (1)
Aaron M Cook, PharmD (1) · Estela M de Oliveira, PhD student (1) · Hsin Lin, PharmD (1) · Juliano P Almeida, Professor (1)
R21AI176298 (1)